<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xml:lang="EN">
<head>
<meta name="viewport" content="width=840, height=1080"/>
<meta charset="utf-8"/>
<title>The Morphology of Human Blood Cells</title>
<link href="template.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<div>
<img class="stl_03" src="images/037.jpg" alt=""/>
<div class="layer">
<div class="stl_04 stl_05">
<div style="position:absolute; top:2.6736em; left:36.8769em;"><span class="stl_535 stl_07 stl_42" style="word-spacing:0.0027em;">The Morphology of</span><span class="stl_535 stl_07 stl_42" style="word-spacing:0.0327em;"> Human</span><span class="stl_535 stl_07 stl_42" style="word-spacing:0.0027em;"> Blood</span><span class="stl_535 stl_07 stl_42" style="word-spacing:0.0027em;"> Cells &#160;</span></div>
<div style="position:absolute; top:6.7573em; left:26.4995em;"><span class="stl_536 stl_07 stl_52" style="word-spacing:0.2762em;">conditions may reach 1000x10</span><sup><span class="stl_537a stl_07 stl_473" style="word-spacing:0.3683em;">9</span></sup><span class="stl_536 stl_07 stl_52" style="word-spacing:0.2762em;">/l; however,</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.2487em;"> this</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.2787em;"> increase &#160;</span></div>
<div style="position:absolute; top:7.7618em; left:26.5002em;"><span class="stl_536 stl_07 stl_61" style="word-spacing:0.0241em;">rarely causes thromboembolic phenomena. &#160;</span></div>
<div style="position:absolute; top:6.6667em; left:5.25em;"><span class="stl_536 stl_07 stl_24" style="word-spacing:0.0955em;">patients with PV presenting as deep venous thrombosis of &#160;</span></div>
<div style="position:absolute; top:7.6663em; left:5.25em;"><span class="stl_536 stl_07 stl_68" style="word-spacing:0.298em;">lower extremities,</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.2884em;"> peripheral vascular disease,</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.2835em;"> and</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.2835em;"> cere- &#160;</span></div>
<div style="position:absolute; top:8.6659em; left:5.25em;"><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0267em;">brovascular accidents. &#160;</span></div>
<div style="position:absolute; top:9.671em; left:26.5em;"><span class="stl_538 stl_89 stl_360">Treatment &#160;</span></div>
<div style="position:absolute; top:10.7622em; left:26.5em;"><span class="stl_536 stl_07 stl_75" style="word-spacing:0.2097em;">Treatment of</span><span class="stl_536 stl_07 stl_75" style="word-spacing:0.2397em;"> ET</span><span class="stl_536 stl_07 stl_75" style="word-spacing:0.2097em;"> aims at reducing the platelet counts</span><span class="stl_536 stl_07 stl_75" style="word-spacing:0.2097em;"> in &#160;</span></div>
<div style="position:absolute; top:11.7618em; left:26.5em;"><span class="stl_536 stl_07 stl_64" style="word-spacing:0.2702em;">symptomatic patients.</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.2302em;"> Recently, Anegrelide</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.0535em;"> ,</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.2402em;"> a</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.2702em;"> drug</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.2702em;"> that &#160;</span></div>
<div style="position:absolute; top:12.7618em; left:26.5002em;"><span class="stl_536 stl_07 stl_41" style="word-spacing:0.0409em;">inhibits megakaryopoiesis,</span><span class="stl_536 stl_07 stl_41" style="word-spacing:0.0109em;"> has</span><span class="stl_536 stl_07 stl_41" style="word-spacing:0.0409em;"> been approved for the</span><span class="stl_536 stl_07 stl_41" style="word-spacing:0.0409em;"> treat- &#160;</span></div>
<div style="position:absolute; top:13.7614em; left:26.5002em;"><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0799em;">ment of</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.1089em;"> ET.</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0499em;"> The</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0799em;"> drug has almost replaced other and</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0799em;"> more &#160;</span></div>
<div style="position:absolute; top:14.761em; left:26.5002em;"><span class="stl_536 stl_07 stl_125" style="word-spacing:0.278em;">toxic treatments such as hydroxyurea.</span><span class="stl_536 stl_07 stl_125" style="word-spacing:0.247em;"> The</span><span class="stl_536 stl_07 stl_125" style="word-spacing:0.278em;"> prognosis</span><span class="stl_536 stl_07 stl_125" style="word-spacing:0.278em;"> of &#160;</span></div>
<div style="position:absolute; top:15.7606em; left:26.5002em;"><span class="stl_536 stl_07 stl_122" style="word-spacing:0.2021em;">patients with ET is usually very good,</span><span class="stl_536 stl_07 stl_122" style="word-spacing:0.1721em;"> provided</span><span class="stl_536 stl_07 stl_122" style="word-spacing:0.2021em;"> that</span><span class="stl_536 stl_07 stl_122" style="word-spacing:0.2021em;"> the &#160;</span></div>
<div style="position:absolute; top:16.7602em; left:26.5002em;"><span class="stl_536 stl_07 stl_87" style="word-spacing:0.027em;">platelet counts are well controlled. &#160;</span></div>
<div style="position:absolute; top:10.5754em; left:5.25em;"><span class="stl_538 stl_89 stl_20" style="word-spacing:0.0267em;">Laboratory Results &#160;</span></div>
<div style="position:absolute; top:11.7902em; left:40.9859em;"><span class="stl_539 stl_07 stl_73">Â®</span></div>
<div style="position:absolute; top:11.6667em; left:5.25em;"><span class="stl_536 stl_07 stl_81" style="word-spacing:0.2648em;">Laboratory results include elevated red blood cells with &#160;</span></div>
<div style="position:absolute; top:12.6663em; left:5.25em;"><span class="stl_536 stl_07 stl_20" style="word-spacing:0.1735em;">hematocrit approaching 80% or higher in some patients. &#160;</span></div>
<div style="position:absolute; top:13.6659em; left:5.25em;"><span class="stl_536 stl_07 stl_44" style="word-spacing:-0.0318em;">Leukocytosis and increased platelet numbers are observed in &#160;</span></div>
<div style="position:absolute; top:14.6655em; left:5.25em;"><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0697em;">more than 50% of</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0987em;"> patients</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0697em;"> with PV.</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0387em;"> Examination</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0697em;"> of</span><span class="stl_536 stl_07 stl_52" style="word-spacing:0.0997em;"> blood &#160;</span></div>
<div style="position:absolute; top:15.6651em; left:5.25em;"><span class="stl_536 stl_07 stl_540" style="word-spacing:0.3204em;">usually reveals anisopoikilocytosis, polychromasia, and &#160;</span></div>
<div style="position:absolute; top:16.6647em; left:5.25em;"><span class="stl_536 stl_07 stl_43" style="word-spacing:0.1568em;">megathrombocytes and some early granulocytes.</span><span class="stl_536 stl_07 stl_43" style="word-spacing:0.1258em;"> Elevated &#160;</span></div>
<div style="position:absolute; top:17.6643em; left:5.25em;"><span class="stl_536 stl_07 stl_124" style="word-spacing:0.0144em;">blood cell mass, normal plasma volume, and normal arteri- &#160;</span></div>
<div style="position:absolute; top:18.6639em; left:5.25em;"><span class="stl_536 stl_07 stl_68" style="word-spacing:0.1341em;">al oxygen saturation usually differentiate between PV and &#160;</span></div>
<div style="position:absolute; top:19.6635em; left:5.25em;"><span class="stl_536 stl_07 stl_352" style="word-spacing:0.0197em;">other causes of</span><span class="stl_536 stl_07 stl_352" style="word-spacing:0.0487em;"> erythrocytosis. &#160;</span></div>
<div style="position:absolute; top:18.8227em; left:26.5em;"><span class="stl_541 stl_171 stl_47" style="word-spacing:0.027em;">Idiopathic Myelofibrosis &#160;</span></div>
<div style="position:absolute; top:20.6631em; left:6.7502em;"><span class="stl_536 stl_07 stl_39" style="word-spacing:0.1123em;">It is estimated that 10% of</span><span class="stl_536 stl_07 stl_39" style="word-spacing:0.1413em;"> patients</span><span class="stl_536 stl_07 stl_39" style="word-spacing:0.1123em;"> with PV</span><span class="stl_536 stl_07 stl_39" style="word-spacing:0.1123em;"> undergo &#160;</span></div>
<div style="position:absolute; top:21.6627em; left:5.25em;"><span class="stl_536 stl_07 stl_111" style="word-spacing:0.1647em;">evolution to myelofibrosis.</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.1357em;"> This</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.1647em;"> phase is characterized</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.1647em;"> by &#160;</span></div>
<div style="position:absolute; top:22.6622em; left:5.25em;"><span class="stl_536 stl_07 stl_125" style="word-spacing:0.3129em;">increasing splenomegaly,</span><span class="stl_536 stl_07 stl_125" style="word-spacing:0.3069em;"> excessive reticulin in the</span><span class="stl_536 stl_07 stl_125" style="word-spacing:0.3069em;"> bone &#160;</span></div>
<div style="position:absolute; top:23.6618em; left:5.25em;"><span class="stl_536 stl_07 stl_532" style="word-spacing:0.3702em;">marrow, and a leukoerythroblastic picture in</span><span class="stl_536 stl_07 stl_532" style="word-spacing:0.3702em;"> blood. &#160;</span></div>
<div style="position:absolute; top:24.6614em; left:5.25em;"><span class="stl_536 stl_07 stl_350" style="word-spacing:0.3438em;">Transformation to acute myeloid leukemia occurs in &#160;</span></div>
<div style="position:absolute; top:25.661em; left:5.25em;"><span class="stl_536 stl_07 stl_51" style="word-spacing:0.0346em;">approximately 9% of</span><span class="stl_536 stl_07 stl_51" style="word-spacing:0.0636em;"> patients</span><span class="stl_536 stl_07 stl_51" style="word-spacing:0.0346em;"> with</span><span class="stl_536 stl_07 stl_51" style="word-spacing:0.0346em;"> PV. &#160;</span></div>
<div style="position:absolute; top:20.5956em; left:26.5em;"><span class="stl_536 stl_07 stl_77" style="word-spacing:-0.0144em;">Idiopathic myelofibrosis is a clonal myeloproliferative disor- &#160;</span></div>
<div style="position:absolute; top:21.5952em; left:26.5em;"><span class="stl_536 stl_07 stl_115" style="word-spacing:0.1395em;">der characterized by the presence of</span><span class="stl_536 stl_07 stl_115" style="word-spacing:0.1695em;"> splenomegaly,</span><span class="stl_536 stl_07 stl_115" style="word-spacing:0.1095em;"> leuko- &#160;</span></div>
<div style="position:absolute; top:22.5948em; left:26.5em;"><span class="stl_536 stl_07 stl_69" style="word-spacing:0.2973em;">erythroblastic blood picture,</span><span class="stl_536 stl_07 stl_69" style="word-spacing:0.2673em;"> excessive</span><span class="stl_536 stl_07 stl_69" style="word-spacing:0.2973em;"> teardrop</span><span class="stl_536 stl_07 stl_69" style="word-spacing:0.2973em;"> erythro- &#160;</span></div>
<div style="position:absolute; top:23.5944em; left:26.5em;"><span class="stl_536 stl_07 stl_37" style="word-spacing:0.0991em;">cytes, marrow</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.1291em;"> fibrosis,</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.0981em;"> and</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.1291em;"> extramedullary</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.1291em;"> hematopoiesis. &#160;</span></div>
<div style="position:absolute; top:24.594em; left:26.5em;"><span class="stl_536 stl_07 stl_41" style="word-spacing:-0.0193em;">The hematopoietic abnormality in myelofibrosis arises from &#160;</span></div>
<div style="position:absolute; top:25.5936em; left:26.5em;"><span class="stl_536 stl_07 stl_77" style="word-spacing:0.0247em;">a defect at the stem cell level.</span><span class="stl_536 stl_07 stl_77" style="word-spacing:-0.0043em;"> However, it</span><span class="stl_536 stl_07 stl_77" style="word-spacing:0.0247em;"> should be</span><span class="stl_536 stl_07 stl_77" style="word-spacing:0.0247em;"> empha- &#160;</span></div>
<div style="position:absolute; top:26.5932em; left:26.5em;"><span class="stl_536 stl_07 stl_41" style="word-spacing:0.0417em;">sized that mesenchymal cells and fibroblasts are not part of &#160;</span></div>
<div style="position:absolute; top:27.5928em; left:26.5em;"><span class="stl_536 stl_07 stl_69" style="word-spacing:0.0505em;">the malignant clone and that marrow fibrosis is considered &#160;</span></div>
<div style="position:absolute; top:28.5924em; left:26.5em;"><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0226em;">secondary or reactive.</span><span class="stl_536 stl_07 stl_15" style="word-spacing:-0.0064em;"> The</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0226em;"> cause of</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0526em;"> fibrosis</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0226em;"> in this disease</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0226em;"> is &#160;</span></div>
<div style="position:absolute; top:29.592em; left:26.5em;"><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0916em;">a matter of</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.1206em;"> some</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0916em;"> debate.</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0616em;"> Dysregulation</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0916em;"> in the synthesis</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.0916em;"> of &#160;</span></div>
<div style="position:absolute; top:30.5916em; left:26.5em;"><span class="stl_536 stl_07 stl_60" style="word-spacing:0.0044em;">collagen, excessive</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.0344em;"> release of</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.0634em;"> growth</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.0344em;"> factors,</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.0044em;"> and</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.0344em;"> abnormal- &#160;</span></div>
<div style="position:absolute; top:31.5912em; left:26.5em;"><span class="stl_536 stl_07 stl_69" style="word-spacing:0.0933em;">ities of</span><span class="stl_536 stl_07 stl_69" style="word-spacing:0.1233em;"> platelet</span><span class="stl_536 stl_07 stl_69" style="word-spacing:0.0933em;"> activation have been implicated as</span><span class="stl_536 stl_07 stl_69" style="word-spacing:0.0933em;"> possible &#160;</span></div>
<div style="position:absolute; top:32.5908em; left:26.5em;"><span class="stl_536 stl_07 stl_99" style="word-spacing:0.0283em;">sources of</span><span class="stl_536 stl_07 stl_99" style="word-spacing:0.0573em;"> marrow</span><span class="stl_536 stl_07 stl_99" style="word-spacing:0.0283em;"> fibrosis. &#160;</span></div>
<div style="position:absolute; top:27.5754em; left:5.25em;"><span class="stl_538 stl_89 stl_360">Treatment &#160;</span></div>
<div style="position:absolute; top:28.6667em; left:5.25em;"><span class="stl_536 stl_07 stl_62" style="word-spacing:0.0282em;">Treatment of</span><span class="stl_536 stl_07 stl_62" style="word-spacing:0.0582em;"> PV</span><span class="stl_536 stl_07 stl_62" style="word-spacing:0.0282em;"> aims at reducing blood cell mass in</span><span class="stl_536 stl_07 stl_62" style="word-spacing:0.0282em;"> symp- &#160;</span></div>
<div style="position:absolute; top:29.6663em; left:5.25em;"><span class="stl_536 stl_07 stl_296" style="word-spacing:0.3296em;">tomatic patients by phlebotomy or other therapeutic &#160;</span></div>
<div style="position:absolute; top:30.6659em; left:5.25em;"><span class="stl_536 stl_07 stl_132">modalities. &#160;</span></div>
<div style="position:absolute; top:32.7271em; left:5.25em;"><span class="stl_541 stl_171 stl_134" style="word-spacing:0.0167em;">Essential Thrombocythemia &#160;</span></div>
<div style="position:absolute; top:34.5em; left:5.25em;"><span class="stl_536 stl_07 stl_21" style="word-spacing:0.0459em;">Essential thrombocythemia (ET) is defined by the presence &#160;</span></div>
<div style="position:absolute; top:34.5043em; left:26.5em;"><span class="stl_538 stl_89 stl_68">Presentation &#160;</span></div>
<div style="position:absolute; top:35.3963em; left:18.1257em;"><span class="stl_537 stl_07 stl_73">9</span></div>
<div style="position:absolute; top:35.4996em; left:5.25em;"><span class="stl_536 stl_07 stl_61" style="word-spacing:0.2341em;">of platelet</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.2051em;"> counts in excess of</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.2341em;"> 600x10</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.1688em;"> /l,</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.1688em;"> megakaryocytic &#160;</span></div>
<div style="position:absolute; top:35.5956em; left:26.5em;"><span class="stl_536 stl_07 stl_335" style="word-spacing:0.3406em;">Like other myeloproliferative disorders,</span><span class="stl_536 stl_07 stl_335" style="word-spacing:0.3251em;"> patients</span><span class="stl_536 stl_07 stl_335" style="word-spacing:0.3251em;"> with &#160;</span></div>
<div style="position:absolute; top:36.5952em; left:26.5em;"><span class="stl_536 stl_07 stl_87" style="word-spacing:0.057em;">myelofibrosis may be asymptomatic and the diagnosis may &#160;</span></div>
<div style="position:absolute; top:37.5948em; left:26.5em;"><span class="stl_536 stl_07 stl_21" style="word-spacing:0.2511em;">be sought after detection of</span><span class="stl_536 stl_07 stl_21" style="word-spacing:0.2801em;"> enlarged</span><span class="stl_536 stl_07 stl_21" style="word-spacing:0.2511em;"> spleen on</span><span class="stl_536 stl_07 stl_21" style="word-spacing:0.2511em;"> routine &#160;</span></div>
<div style="position:absolute; top:38.5944em; left:26.5em;"><span class="stl_536 stl_07 stl_61" style="word-spacing:0.0211em;">physical examination or because of</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.0501em;"> an</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.0212em;"> abnormal blood</span><span class="stl_536 stl_07 stl_61" style="word-spacing:0.0212em;"> pic- &#160;</span></div>
<div style="position:absolute; top:39.594em; left:26.5em;"><span class="stl_536 stl_07 stl_210" style="word-spacing:0.3382em;">ture. The most common symptoms are fatigue,</span><span class="stl_536 stl_07 stl_210" style="word-spacing:0.3132em;"> fever, &#160;</span></div>
<div style="position:absolute; top:40.5936em; left:26.5em;"><span class="stl_536 stl_07 stl_542" style="word-spacing:0.3193em;">abdominal discomfort, weight loss, and night</span><span class="stl_536 stl_07 stl_542" style="word-spacing:0.3193em;"> sweats. &#160;</span></div>
<div style="position:absolute; top:41.5932em; left:26.5em;"><span class="stl_536 stl_07 stl_115" style="word-spacing:0.1793em;">Moderate to massive splenomegaly is present in approxi- &#160;</span></div>
<div style="position:absolute; top:42.5928em; left:26.5em;"><span class="stl_536 stl_07 stl_40" style="word-spacing:0.1424em;">mately 90% of</span><span class="stl_536 stl_07 stl_40" style="word-spacing:0.1704em;"> patients.</span><span class="stl_536 stl_07 stl_40" style="word-spacing:0.1114em;"> The</span><span class="stl_536 stl_07 stl_40" style="word-spacing:0.1424em;"> spleen has the</span><span class="stl_536 stl_07 stl_40" style="word-spacing:0.1424em;"> extraordinary &#160;</span></div>
<div style="position:absolute; top:43.5924em; left:26.5em;"><span class="stl_536 stl_07 stl_41" style="word-spacing:-0.0144em;">ability of accommodating a large blood volume and increas- &#160;</span></div>
<div style="position:absolute; top:44.592em; left:26.5em;"><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0236em;">ing growth of</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0526em;"> hematopoietic</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0236em;"> elements. &#160;</span></div>
<div style="position:absolute; top:36.4996em; left:5.2502em;"><span class="stl_536 stl_07 stl_64" style="word-spacing:-0.0209em;">hyperplasia, splenomegaly, and</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.0091em;"> absence of</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.0381em;"> Ph</span><span class="stl_536 stl_07 stl_64" style="word-spacing:0.0091em;"> chromosome. &#160;</span></div>
<div style="position:absolute; top:37.4992em; left:5.2502em;"><span class="stl_536 stl_07 stl_41" style="word-spacing:0.0688em;">The disease is considered a clonal hematopoietic neoplasm &#160;</span></div>
<div style="position:absolute; top:38.4988em; left:5.2502em;"><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0236em;">originating at the level of</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0526em;"> the</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0236em;"> stem</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0236em;"> cell. &#160;</span></div>
<div style="position:absolute; top:40.4087em; left:5.25em;"><span class="stl_538 stl_89 stl_68" style="word-spacing:0.0284em;">Clinical Features &#160;</span></div>
<div style="position:absolute; top:41.5em; left:5.25em;"><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0208em;">The average age of</span><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0498em;"> patients</span><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0208em;"> at the time of</span><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0498em;"> diagnosis</span><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0208em;"> of</span><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0498em;"> ET</span><span class="stl_536 stl_07 stl_138" style="word-spacing:0.0208em;"> is &#160;</span></div>
<div style="position:absolute; top:42.4996em; left:5.25em;"><span class="stl_536 stl_07 stl_60" style="word-spacing:0.2325em;">55 years.</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.2025em;"> Increased</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.2325em;"> platelet counts may be an</span><span class="stl_536 stl_07 stl_60" style="word-spacing:0.2325em;"> incidental &#160;</span></div>
<div style="position:absolute; top:43.4992em; left:5.25em;"><span class="stl_536 stl_07 stl_24" style="word-spacing:0.0154em;">finding or patients may present with bleeding or thrombot- &#160;</span></div>
<div style="position:absolute; top:44.4988em; left:5.25em;"><span class="stl_536 stl_07 stl_87" style="word-spacing:0.1011em;">ic problems.</span><span class="stl_536 stl_07 stl_87" style="word-spacing:0.0711em;"> Splenomegaly</span><span class="stl_536 stl_07 stl_87" style="word-spacing:0.1011em;"> can be found in</span><span class="stl_536 stl_07 stl_87" style="word-spacing:0.1011em;"> approximately &#160;</span></div>
<div style="position:absolute; top:45.4984em; left:5.25em;"><span class="stl_536 stl_07 stl_158" style="word-spacing:0.0329em;">40% of</span><span class="stl_536 stl_07 stl_158" style="word-spacing:0.0619em;"> patients</span><span class="stl_536 stl_07 stl_158" style="word-spacing:0.0329em;"> with</span><span class="stl_536 stl_07 stl_158" style="word-spacing:0.0329em;"> ET. &#160;</span></div>
<div style="position:absolute; top:46.5043em; left:26.5em;"><span class="stl_538 stl_89 stl_41" style="word-spacing:-0.0001em;">Hematology Findings &#160;</span></div>
<div style="position:absolute; top:47.4087em; left:5.25em;"><span class="stl_538 stl_89 stl_21" style="word-spacing:0.027em;">Laboratory Examination &#160;</span></div>
<div style="position:absolute; top:47.5956em; left:26.5em;"><span class="stl_536 stl_07 stl_42" style="word-spacing:0.1889em;">Blood examination in myelofibrosis is characterized by a &#160;</span></div>
<div style="position:absolute; top:48.5952em; left:26.5em;"><span class="stl_536 stl_07 stl_24" style="word-spacing:0.0773em;">leukoerythroblastic picture (nucleated red cells and imma- &#160;</span></div>
<div style="position:absolute; top:49.5948em; left:26.5em;"><span class="stl_536 stl_07 stl_87" style="word-spacing:-0.0534em;">ture myeloid elements), teardrop cells (</span><span class="stl_543 stl_07 stl_64" style="word-spacing:-0.0584em;">PLATES </span><span class="stl_536 stl_07 stl_87" style="word-spacing:-0.0534em;">31, 57), giant &#160;</span></div>
<div style="position:absolute; top:50.5952em; left:26.5002em;"><span class="stl_536 stl_07 stl_240" style="word-spacing:-0.0709em;">platelets (</span><span class="stl_543 stl_07 stl_106" style="word-spacing:-0.0775em;">PLATE </span><span class="stl_536 stl_07 " style="word-spacing:-0.0709em;">73) and megakaryocytic fragments.Anemia</span></div>
<div style="position:absolute; top:51.5952em; left:26.4998em;"><span class="stl_536 stl_07 stl_136" style="word-spacing:-0.0582em;">is a constant feature of myelofibrosis and is caused by ineffec- &#160;</span></div>
<div style="position:absolute; top:52.5948em; left:26.4998em;"><span class="stl_536 stl_07 stl_37" style="word-spacing:0.0852em;">tive erythropoiesis,</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.0542em;"> hemolysis</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.0852em;"> and hemodilution caused</span><span class="stl_536 stl_07 stl_37" style="word-spacing:0.0852em;"> by &#160;</span></div>
<div style="position:absolute; top:53.5944em; left:26.4998em;"><span class="stl_536 stl_07 stl_35" style="word-spacing:0.0536em;">increased blood volume.</span><span class="stl_536 stl_07 stl_35" style="word-spacing:0.0236em;"> The</span><span class="stl_536 stl_07 stl_35" style="word-spacing:0.0536em;"> platelets are usually</span><span class="stl_536 stl_07 stl_35" style="word-spacing:0.0536em;"> increased &#160;</span></div>
<div style="position:absolute; top:54.594em; left:26.4998em;"><span class="stl_536 stl_07 stl_35" style="word-spacing:0.0586em;">while leukopenia and leukocytosis are common findings in &#160;</span></div>
<div style="position:absolute; top:55.5936em; left:26.4998em;"><span class="stl_536 stl_07 stl_68" style="word-spacing:-0.0508em;">myelofibrosis. The bone marrow is inaspirable in the majori- &#160;</span></div>
<div style="position:absolute; top:56.5932em; left:26.4998em;"><span class="stl_536 stl_07 stl_68" style="word-spacing:0.122em;">ty of</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.151em;"> patients.</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.091em;"> Marrow</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.122em;"> biopsy usually reveals fibrosis</span><span class="stl_536 stl_07 stl_68" style="word-spacing:0.122em;"> with &#160;</span></div>
<div style="position:absolute; top:57.5928em; left:26.4998em;"><span class="stl_536 stl_07 stl_122" style="word-spacing:-0.0637em;">patches of cellularity and increased megakaryocytes. &#160;</span></div>
<div style="position:absolute; top:48.5em; left:5.25em;"><span class="stl_536 stl_07 stl_544" style="word-spacing:0.5118em;">Blood examination usually reveals the presence of &#160;</span></div>
<div style="position:absolute; top:49.4996em; left:5.25em;"><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0197em;">anisopoikilocytosis, thrombocytosis</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0197em;"> (</span><span class="stl_543 stl_07 stl_15" style="word-spacing:0.0543em;">PLATE</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.089em;"> 57),</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.0207em;"> immature &#160;</span></div>
<div style="position:absolute; top:50.4996em; left:5.2499em;"><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0887em;">myeloid precursors,</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0597em;"> nucleated</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0887em;"> red cells,</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0597em;"> and</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0887em;"> large</span><span class="stl_536 stl_07 stl_111" style="word-spacing:0.0887em;"> platelets. &#160;</span></div>
<div style="position:absolute; top:51.4992em; left:5.2499em;"><span class="stl_536 stl_07 stl_15" style="word-spacing:0.2106em;">In most patients,</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.1816em;"> the</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.2106em;"> bone marrow is hypercellular</span><span class="stl_536 stl_07 stl_15" style="word-spacing:0.2106em;"> with &#160;</span></div>
<div style="position:absolute; top:52.4988em; left:5.2499em;"><span class="stl_536 stl_07 stl_43" style="word-spacing:0.3396em;">increased megakaryocytes. Most patients with ET</span><span class="stl_536 stl_07 stl_43" style="word-spacing:0.3396em;"> have &#160;</span></div>
<div style="position:absolute; top:53.4984em; left:5.2499em;"><span class="stl_536 stl_07 stl_138" style="word-spacing:-0.0081em;">abnormal platelet functions which may explain the bleeding &#160;</span></div>
<div style="position:absolute; top:54.498em; left:5.2499em;"><span class="stl_536 stl_07 stl_20" style="word-spacing:0.2886em;">and thrombotic manifestations of</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.3036em;"> this disease.</span><span class="stl_536 stl_07 stl_20" style="word-spacing:0.2586em;"> Essential &#160;</span></div>
<div style="position:absolute; top:55.4976em; left:5.2499em;"><span class="stl_536 stl_07 stl_24" style="word-spacing:0.0904em;">thrombocythemia should be differentiated from other dis- &#160;</span></div>
<div style="position:absolute; top:56.4972em; left:5.2499em;"><span class="stl_536 stl_07 stl_41" style="word-spacing:0.2797em;">orders that cause increase in platelet counts.</span><span class="stl_536 stl_07 stl_41" style="word-spacing:0.2497em;"> Secondary &#160;</span></div>
<div style="position:absolute; top:57.4968em; left:5.2499em;"><span class="stl_536 stl_07 stl_138" style="word-spacing:0.1468em;">thrombocytosis can be present in patients with iron defi- &#160;</span></div>
<div style="position:absolute; top:58.4964em; left:5.2499em;"><span class="stl_536 stl_07 stl_296" style="word-spacing:0.3236em;">ciency anemia, chronic inflammatory disease such</span><span class="stl_536 stl_07 stl_296" style="word-spacing:0.3236em;"> as &#160;</span></div>
<div style="position:absolute; top:59.496em; left:5.2499em;"><span class="stl_536 stl_07 stl_62" style="word-spacing:0.2953em;">Crohnâs disease and rheumatoid arthritis,</span><span class="stl_536 stl_07 stl_62" style="word-spacing:0.2653em;"> some</span><span class="stl_536 stl_07 stl_62" style="word-spacing:0.2953em;"> chronic &#160;</span></div>
<div style="position:absolute; top:60.4956em; left:5.2499em;"><span class="stl_536 stl_07 stl_38" style="word-spacing:-0.0127em;">infections, and in patients with underlying malignancy such &#160;</span></div>
<div style="position:absolute; top:61.4952em; left:5.2499em;"><span class="stl_536 stl_07 stl_299" style="word-spacing:0.3459em;">as lung or colon cancer.</span><span class="stl_536 stl_07 stl_299" style="word-spacing:0.3399em;"> The platelet counts in</span><span class="stl_536 stl_07 stl_299" style="word-spacing:0.3399em;"> these &#160;</span></div>
<div style="position:absolute; top:59.5043em; left:26.5em;"><span class="stl_538 stl_89 stl_360">Treatment &#160;</span></div>
<div style="position:absolute; top:60.5956em; left:26.5em;"><span class="stl_536 stl_07 stl_545" style="word-spacing:0.2197em;">Treatment options range from watchful follow-up and &#160;</span></div>
<div style="position:absolute; top:61.5952em; left:26.5em;"><span class="stl_536 stl_07 stl_40" style="word-spacing:-0.0006em;">transfusion support to bone marrow transplantation. &#160;</span></div>
<div style="position:absolute; top:64.0452em; left:47.9161em;"><span class="stl_546 stl_89 stl_210">29 &#160;</span></div>
</div>
</div>
</div>
</body>
</html>
